Elanco Animal Health 

$24.56
51
+$0.48+1.99% Today

Statistics

Day High
24.59
Day Low
23.96
52W High
25.29
52W Low
8.02
Volume
1,291,540
Avg. Volume
5,427,385
Mkt Cap
12.2B
P/E Ratio
25.17
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.11
0.2
0.28
0.37
Expected EPS
0.11346
Actual EPS
N/A

Financials

7.61%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
8.88BRevenue
676MNet Income

Analyst Ratings

$26.14Average Price Target
The highest estimate is 30.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
86%
Hold
14%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ELAN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap63.86B
Zoetis is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, directly competing with Elanco in both the companion and livestock animal product markets.
Merck
MRK
Mkt Cap214.76B
Merck & Co., through its animal health division, offers veterinary pharmaceuticals, vaccines, and health management solutions and services, making it a direct competitor to Elanco in multiple segments of the animal health industry.
Phibro Animal Health
PAHC
Mkt Cap1.76B
Phibro Animal Health Corporation operates in the animal health and mineral nutrition markets, offering medicated feed additives, which puts it in direct competition with Elanco's product offerings.
Idexx Laboratories
IDXX
Mkt Cap50.36B
IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, livestock, and poultry services, competing with Elanco in the animal health diagnostics market.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories, through its animal health division (before divestiture), offered products that competed with Elanco in diagnostics and nutrition, although its focus has shifted, it remains a competitor through legacy products and technologies.
Pfizer
PFE
Mkt Cap140.15B
Pfizer, prior to the spin-off of its animal health division into Zoetis, was a direct competitor in the development and commercialization of animal health products, and it maintains a presence in the market through ongoing investments and partnerships.
Elia Group SA/NV
ELI.BR
Mkt Cap11.6B
Elia System Operator provides infrastructure and services for the energy sector but is included erroneously as it does not compete in the animal health sector, illustrating the importance of accurate industry classification.

About

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Show more...
CEO
Mr. Jeffrey N. Simmons
Employees
9000
Country
US
ISIN
US28414H1032

Listings

0 Comments

Share your thoughts

FAQ

What is Elanco Animal Health stock price today?
The current price of ELAN is $24.56 USD — it has increased by +1.99% in the past 24 hours. Watch Elanco Animal Health stock price performance more closely on the chart.
What is Elanco Animal Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Elanco Animal Health stocks are traded under the ticker ELAN.
Is Elanco Animal Health stock price growing?
ELAN stock has fallen by -0.49% compared to the previous week, the month change is a +9.06% rise, over the last year Elanco Animal Health has showed a +104.16% increase.
What is Elanco Animal Health market cap?
Today Elanco Animal Health has the market capitalization of 12.2B
When is the next Elanco Animal Health earnings date?
Elanco Animal Health is going to release the next earnings report on February 24, 2026.
What were Elanco Animal Health earnings last quarter?
ELAN earnings for the last quarter are 0.19 USD per share, whereas the estimation was 0.13 USD resulting in a +46.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Elanco Animal Health revenue for the last year?
Elanco Animal Health revenue for the last year amounts to 8.88B USD.
What is Elanco Animal Health net income for the last year?
ELAN net income for the last year is 676M USD.
How many employees does Elanco Animal Health have?
As of February 02, 2026, the company has 9,000 employees.
In which sector is Elanco Animal Health located?
Elanco Animal Health operates in the Health Care sector.
When did Elanco Animal Health complete a stock split?
Elanco Animal Health has not had any recent stock splits.
Where is Elanco Animal Health headquartered?
Elanco Animal Health is headquartered in Greenfield, US.